Phillip Nalbone

Phillip Nalbone currently serves as the VP of Corporate Development & Investor Relations at Imperative Care, where responsibilities include overseeing corporate development for four interconnected businesses in the stroke treatment sector. In addition, Phillip holds the position of Chair of the Board of Directors at the Robert H. Jackson Center and is a member of the Board of Directors at Reprise Biomedical, which focuses on biologic medical devices for wound healing. Prior experience includes consulting at PEN Research & Analysis, as well as various roles in corporate development and investor relations at Teleflex Incorporated and Vascular Solutions. Phillip's career began in journalism at Dow Jones Newswires/The Wall Street Journal, where coverage spanned medical technology and healthcare economics. Education includes a Bachelor of Arts in Economics and Government from St. Lawrence University, supplemented by studies at institutions in Nairobi, New York, and Madrid.